These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
423 related items for PubMed ID: 22928863
1. In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii. Pei G, Mao Y, Sun Y. Microb Drug Resist; 2012 Dec; 18(6):574-7. PubMed ID: 22928863 [Abstract] [Full Text] [Related]
2. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii. Liu B, Bai Y, Liu Y, Di X, Zhang X, Wang R, Wang J. J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186 [Abstract] [Full Text] [Related]
3. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates]. Turk Dagi H, Kus H, Arslan U, Tuncer I. Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268 [Abstract] [Full Text] [Related]
4. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. Karaoglan I, Zer Y, Bosnak VK, Mete AO, Namiduru M. J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334 [Abstract] [Full Text] [Related]
5. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam. Xia J, Zhang D, Xu Y, Gong M, Zhou Y, Fang X. Int J Infect Dis; 2014 Jun; 23():90-3. PubMed ID: 24726664 [Abstract] [Full Text] [Related]
6. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro]. Zhao C, Xie W, Zhang W, Ye Z, Wu H. Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663 [Abstract] [Full Text] [Related]
7. In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii. Wang Y, Li X, Wang D, Sun S, Lu C. Lett Appl Microbiol; 2020 Mar; 70(3):189-195. PubMed ID: 31808159 [Abstract] [Full Text] [Related]
8. Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility. Abbey T, Vialichka A, Jurkovic M, Biagi M, Wenzler E. Microbiol Spectr; 2022 Jun 29; 10(3):e0054222. PubMed ID: 35647655 [Abstract] [Full Text] [Related]
9. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii. Dong X, Chen F, Zhang Y, Liu H, Liu Y, Ma L. J Antibiot (Tokyo); 2014 Sep 29; 67(9):677-80. PubMed ID: 25095805 [Abstract] [Full Text] [Related]
11. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units. Ozbek B, Otük G. Int J Antimicrob Agents; 2010 Aug 29; 36(2):191-2. PubMed ID: 20537868 [No Abstract] [Full Text] [Related]
12. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, Cheong HJ. J Antimicrob Chemother; 2007 Aug 29; 60(2):317-22. PubMed ID: 17540672 [Abstract] [Full Text] [Related]
13. Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model. Beganovic M, Daffinee KE, Luther MK, LaPlante KL. Antimicrob Agents Chemother; 2021 Feb 17; 65(3):. PubMed ID: 33318006 [Abstract] [Full Text] [Related]
14. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU. Sheng WH, Wang JT, Li SY, Lin YC, Cheng A, Chen YC, Chang SC. Diagn Microbiol Infect Dis; 2011 Jul 17; 70(3):380-6. PubMed ID: 21558048 [Abstract] [Full Text] [Related]
15. Enhanced bacterial killing with a combination of sulbactam/minocycline against dual carbapenemase-producing Acinetobacter baumannii. Chandran S, Manokaran Y, Vijayakumar S, Shankar BA, Bakthavatchalam YD, Dwarakanathan HT, Yesudason BL, Veeraraghavan B. Eur J Clin Microbiol Infect Dis; 2023 May 17; 42(5):645-651. PubMed ID: 36905566 [Abstract] [Full Text] [Related]
16. In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp. Tong W, Wang R, Chai D, Li Z, Pei F. Int J Antimicrob Agents; 2006 Nov 17; 28(5):454-6. PubMed ID: 16987639 [Abstract] [Full Text] [Related]
17. In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii. Kiffer CR, Sampaio JL, Sinto S, Oplustil CP, Koga PC, Arruda AC, Turner PJ, Mendes C. Diagn Microbiol Infect Dis; 2005 Aug 17; 52(4):317-22. PubMed ID: 15936166 [Abstract] [Full Text] [Related]
18. Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii. Temocin F, Erdinc FS, Tulek N, Demirelli M, Ertem G, Kinikli S, Koksal E. Braz J Microbiol; 2015 Aug 17; 46(4):1119-24. PubMed ID: 26691470 [Abstract] [Full Text] [Related]
19. In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection. Principe L, Capone A, Mazzarelli A, D'Arezzo S, Bordi E, Di Caro A, Petrosillo N. Microb Drug Resist; 2013 Oct 17; 19(5):407-14. PubMed ID: 23659601 [Abstract] [Full Text] [Related]
20. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates. Deveci A, Coban AY, Acicbe O, Tanyel E, Yaman G, Durupinar B. J Chemother; 2012 Oct 17; 24(5):247-52. PubMed ID: 23182043 [Abstract] [Full Text] [Related] Page: [Next] [New Search]